2025
World’s first CE-certified AI medical device transforming cancer detection in radiology.
Better Medicine
AI-powered radiology software transforming cancer diagnostics – the world’s first CE-certified solution, starting with kidney cancer and paving the way for multi-organ detection.
Milestones
Lead Investment, 2025
Team
Priit Salumaa - CEO
Dmytro Fishman - CSO
Martin Reim - Advisor
Helena Ije - COO
Bohdan Petryshak - Chief of AI Engineering
Sergei Gussev - CTO
Partners
Soulmates Ventures
Specialist VC
UT Ventures
Superangel
The Solution
Better Medicine is redefining cancer diagnostics with AI-powered radiology software. Its flagship, BMVision Kidney, is the first CE-certified medical device under EU MDR Class IIa that automatically identifies, classifies, and measures kidney tumors on CT scans. Alongside it, iMeasure standardises tumor volume tracking across organs. Together, they give radiologists powerful decision-support tools that cut evaluation time and increase accuracy.
The Uniqueness
Better Medicine is not building a single niche tool, but a multi-organ AI platform – from kidney to liver, pancreas, lymph nodes, and bones. Its CE certification secures regulatory trust, its proprietary dataset builds defensibility, and its clinical use already shows results: tumor detection 52% faster with up to 99.2% accuracy.
The Challenges
- Cancer incidence in Europe is set to rise by >50% by 2040.
- Over 40% of kidney cancers are still detected late.
- Radiologist shortages cause critical delays.
Better Medicine directly tackles these challenges by saving radiologists millions of hours annually and enabling earlier interventions.
The Purpose
Founded to improve how cancer is diagnosed and monitored, Better Medicine empowers physicians with intelligent tools that reduce time pressure and cognitive burden, enabling earlier and better treatment decisions.
The Profit
The AI medical imaging market is projected to exceed $11bn by 2030. With a SaaS model for hospitals and imaging centers, recurring revenue streams, and a scalable multi-organ roadmap, Better Medicine is positioned for rapid growth. Validated by clinical partners such as Leeds Teaching Hospitals and University of Tartu, the company is expanding across Europe with solutions that drive efficiency, healthcare sustainability, and long-term market value.
Sources:
- https://bettermedicine.ai/
- https://www.radmagazine.com/better-medicine-launches-the-worlds-first-ce-certified-artificial-intelligence-solution-for-kidney-cancer-detection/
- https://tradewithestonia.com/better-medicine-developed-the-worlds-first-clinically-validated-ai-solution-for-cancer-detection/
- https://investinestonia.com/estonias-healthtech-startup-better-medicine-streamlines-cancer-diagnosis-with-ai-to-the-rescue/
- https://cancerimage.eu/partners/better-medicine/
- https://www.sciencedirect.com/science/article/pii/S2452318625000029
- https://e-estonia.com/modern-cancer-diagnosis-ai-to-the-rescue/
- https://www.nature.com/articles/s41591-025-03785-6
- https://healthcare-in-europe.com/en/news/philips-eucaim-precision-medicine-europe-cancer.html
- https://pitchbook.com/profiles/company/515300-86